CREDIT AGREEMENT dated as of March 20, 2017 by and between AVEDRO, INC., as the Borrower, and ORBIMED ROYALTY OPPORTUNITIES II, LP, as the LenderCredit Agreement • January 18th, 2019 • Avedro Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 18th, 2019 Company Industry JurisdictionTHIS CREDIT AGREEMENT dated as of March 20, 2017 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is by and between AVEDRO, INC., a Delaware corporation (the “Borrower”) and ORBIMED ROYALTY OPPORTUNITIES II, LP, a Delaware limited partnership (together with its Affiliates, successors, transferees and assignees, the “Lender”). The Borrower and the Lender are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
CREDIT AGREEMENT dated as of March 20, 2017 by and between AVEDRO, INC., as the Borrower, and ORBIMED ROYALTY OPPORTUNITIES II, LP, as the LenderCredit Agreement • November 19th, 2018 • Avedro Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 19th, 2018 Company Industry JurisdictionTHIS CREDIT AGREEMENT dated as of March 20, 2017 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is by and between AVEDRO, INC., a Delaware corporation (the “Borrower”) and ORBIMED ROYALTY OPPORTUNITIES II, LP, a Delaware limited partnership (together with its Affiliates, successors, transferees and assignees, the “Lender”). The Borrower and the Lender are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.